Novel and Potent Inhibitors of 5-Lipoxygenase Product Synthesis Based on the Structure of Pirinixic Acid
- 19 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (17) , 5449-5453
Abstract
A novel class of potent 5-lipoxygenase (5-LO) product synthesis inhibitors based on the structure of pirinixic acid (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid, compound 1) is presented. Systematic profiling of 1, i.e., esterification of the carboxylic acid, α-substitution, and replacement of the o-dimethylaniline by 6-aminoquinoline, leads to potent suppressors of 5-LO product formation in activated polymorphonuclear leukocytes, exemplified by ethyl 2-[4-chloro-6-(quinoline-6-ylamino)-pyrimidin-2-ylsulfanyl]octane-1-carboxylate (6d, IC50 = 0.6 μM). These derivatives may possess potential for intervention with inflammatory and allergic diseases.Keywords
This publication has 20 references indexed in Scilit:
- α‐Alkyl Substituted Pirinixic Acid Derivatives as Potent Dual Agonists of the Peroxisome Proliferator Activated Receptor Alpha and GammaArchiv der Pharmazie, 2008
- What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseasesTrends in Pharmacological Sciences, 2008
- LeukotrienesNew England Journal of Medicine, 2007
- Quinoline‐Based Derivatives of Pirinixic Acid as Dual PPAR α/γ AgonistsArchiv der Pharmazie, 2007
- 5-Lipoxygenase: regulation of expression and enzyme activityTrends in Biochemical Sciences, 2007
- Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4productionProceedings of the National Academy of Sciences, 2006
- Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: Effects of the PPAR-α agonist WY14643Free Radical Biology and Medicine, 2006
- Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1Biochemical Journal, 2006
- WY 14643, A POTENT EXOGENOUS PPAR-?? LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCKShock, 2004
- The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessmentToxicology Letters, 1992